Report
The CASH (color, architecture, symmetry, and homogeneity) algorithm for dermoscopy

https://doi.org/10.1016/j.jaad.2006.09.003Get rights and content

Background

The color, architecture, symmetry, and homogeneity (CASH) algorithm for dermoscopy includes a feature not used in prior algorithms, namely, architecture. Architectural order/disorder is derived from current concepts regarding the biology of benign versus malignant melanocytic neoplasms.

Objective

We sought to evaluate the accuracy of the CASH algorithm.

Methods

A total CASH score (TCS) was calculated for dermoscopic images of 325 melanocytic neoplasms. Sensitivity, specificity, diagnostic accuracy, and receiver operating characteristic curve analyses were performed by comparing the TCS with the histopathologic diagnoses for all lesions.

Results

The mean TCS was 12.28 for melanoma, 7.62 for dysplastic nevi, and 5.24 for nondysplastic nevi. These differences were statistically significant (P < .001). A TCS of 8 or more yielded a sensitivity of 98% and specificity of 68% for the diagnosis of melanoma.

Limitations

This is a single-evaluator pilot study. Additional studies are needed to verify the CASH algorithm.

Conclusions

The CASH algorithm can distinguish melanoma from melanocytic nevi with sensitivity and specificity comparable with other algorithms. Further study is warranted to determine its intraobserver and interobserver correlations.

Section snippets

Methods

Most dermoscopic algorithms begin with a two-step procedure. In step one, the PLS are classified as melanocytic or nonmelanocytic. Accordingly, only melanocytic neoplasms were included in this study set.

For this study, the digital dermoscopic images of melanocytic neoplasms were selected from the following databases: (1) New York University Department of Dermatology Pigmented Lesion Clinic; (2) Consensus Net Meeting (with the permission of Drs Argenziano and Soyer); (3) Consortium of

Results

A total of 325 melanocytic neoplasms were studied. Included in the data set were 131 MMs, 70 DN, and 124 MN (Table I). The mean TCS for the 3 populations of melanocytic neoplasms were as follows: MM 12.28 (SD 2.47); DN 7.62 (SD 2.49); and MN 5.24 (SD 2.47). The mean TCS for MM was significantly greater than for DN (P < .001) and for MN (P < .0001) (Fig 3). Combining the TCS for DN and MN gave a mean TCS of 7.62 (SD 2.67), which was significantly different from the MM mean TCS of 12.28 (P <

Discussion

This cross-sectional pilot study demonstrates that the CASH algorithm can distinguish benign from malignant melanocytic neoplasms with a level of sensitivity, specificity, and diagnostic accuracy comparable with other verified dermoscopic algorithms (Table IV).

Pattern analysis, or modifications thereof, is probably the most widely used algorithm by dermoscopists.7 However, this method requires considerable dermoscopic experience. The CASH algorithm is a simplified version of pattern analysis,

References (14)

There are more references available in the full text version of this article.

Cited by (196)

  • A novel approach for skin lesion symmetry classification with a deep learning model

    2022, Computers in Biology and Medicine
    Citation Excerpt :

    These systems simulate expert-designed diagnostic methods, to quantify the malignancy of the lesions based on the appearance of specific structures. Some of these diagnostic methods are pattern analysis Pehamberger, Steiner, and Wolff [3]; the ABCD rule Stolz [4]; the 7-point checklist Argenziano, Fabbrocini, Carli, De Giorgi, Sammarco, and Delfino [5]; the Menzies method Menzies, Ingvar, Crotty, and McCarthy [6]; the CASH method Henning, Dusza, Wang, Marghoob, Rabinovitz, Polsky, and Kopf [7] and the Chaos & Clues method Kittler [8]. In most of these protocols, the symmetry of lesions plays a key role, although not all of them have the same definition of symmetry.

View all citing articles on Scopus

Supported by the Stavros S. Niarchos Foundation, The Rahr Family Foundation.

Conflicts of interest: None identified.

Presented at the First Congress of the International Dermoscopy Society, Naples, Italy, on April 25-29, 2006.

The opinions expressed here are the private views of the authors and do not represent the official position of the Department of the Army.

View full text